7 nominees · 5 ballot items.
Election of seven directors; advisory approval of named executive officer compensation and the frequency of future advisory votes on compensation; approval to issue common stock upon redemption of Series C preferred stock under NYSE Rule 312.03; and ratification of KPMG as independent auditor.
Elect seven directors to serve until the 2027 annual meeting.
Non-binding, advisory vote to approve the overall compensation of the Company’s named executive officers as disclosed in the proxy statement.
This proposal requests a non-binding, advisory approval of the Company’s named executive officer (NEO) compensation as disclosed in the proxy statement, including narrative and tabular disclosures. Management is seeking shareholder approval to obtain investor feedback on its compensation practices despite the Company being externally managed and the NEOs receiving compensation from the Manager rather than directly from the Company. The Board and compensation committee recommend approval, noting that any outcome will be considered when evaluating future compensation program changes. Key context: the Company is externally managed under a Management Agreement that pays a 1.5% annual fee and reimburses certain operating expenses, and NEOs are employees of the Manager, so cash compensation is not paid directly by the Company though equity awards may be granted by the Company. The advisory nature means the vote will not change contractual arrangements but serves as a governance signal; the compensation committee uses the result when assessing alignment with stockholder interests. Given the external management structure, the substantive impact of a “for” vote is largely reputational and advisory, intended to provide the Board with support for the compensation approach described. Voters should consider disclosure about the Manager’s role in setting NEO pay, the amounts reported for stock awards and the Company’s pay-versus-performance tables when assessing the merits. A sophisticated analyst should weigh that management seeks endorsement of disclosed practices while recognizing the limits on the Company’s direct control over cash compensation, and should monitor whether post-vote actions by the compensation committee align with the advisory outcome.
Non-binding, advisory vote for stockholders to indicate whether advisory votes on executive compensation should occur every one, two or three years (management recommends every year).
This advisory proposal asks shareholders to indicate their preferred frequency (every one, two, or three years, or abstain) for future advisory votes on named executive officer compensation. Management’s Board recommends a one-year frequency, arguing that annual votes provide timely, direct input from stockholders on compensation policies and practices. The vote is non-binding, but the Board will consider the results when deciding future frequency. In the Company’s context—where the Company is externally managed and cash compensation to NEOs is paid by the Manager rather than the Company—the annual frequency offers shareholders a regular mechanism to register their views despite limited direct control over cash pay. An annual vote increases engagement and accountability, particularly for a governance model with significant related-party arrangements and an active Manager; however, it can also produce advisory noise and short-term shareholder pressure. Analysts should consider whether annual votes meaningfully influence compensation given the Manager’s role in setting pay, and weigh the trade-offs between responsiveness to stockholders and governance stability. The Board’s clear recommendation for a 1-year frequency and its commitment to evaluate results suggests management expects regular input, but the non-binding nature means substantive change would require follow-up actions from the compensation committee. Overall, the proposal is a governance mechanism rather than a compensation rule change; its practical impact will depend on the Board’s responsiveness to voting outcomes and any subsequent adjustments to compensation disclosure or practices.
Approve, under NYSE Rule 312.03, the issuance of common stock generally and to related parties that may be issued upon redemption of Series C Preferred Stock sold in a registered continuous offering, including possible issuances that would exceed NYSE thresholds.
This management proposal seeks stockholder approval under NYSE Section 312.03 to allow the Company flexibility to satisfy redemptions of Series C preferred stock with shares of common stock, including instances where the issuance might be to related parties or exceed NYSE thresholds (1%, 5% or 20% triggers). The Offering for Series C Preferred Stock was launched as a continuous registered offering and contains redemption features that allow holders to require redemption or allow the Company to redeem after specified periods, with the Company able to settle redemptions in cash or in shares based on market price. Because the Company’s friends-and-family allocations may permit Related Parties (manager, affiliates, directors, officers) to acquire Series C shares, redemptions paid in common stock could result in issuances that would otherwise require prior NYSE approval. Management is therefore asking shareholders to pre-approve such potential issuances to remain compliant and retain operational flexibility to elect stock or cash redemptions. The Board unanimously recommends approval, framing it as a technical but material governance step to avoid automatic breaches of NYSE rules as redemptions occur. Analysts should note the related-party element—discounted placements to insiders under the program—and consider dilution risk if redemptions are satisfied in common stock; the vote does not itself authorize specific issuances but provides the required blanket approval under Section 312.03 for potential future redemptions. Given the trade-off between liquidity management for preferred holders and potential dilution to common shareholders (especially if many preferred holders are related parties), investors should weigh the Company’s capital strategy, the scale of the Offering relative to outstanding common shares, and the likelihood management elects stock versus cash upon redemptions. The approval is primarily regulatory and compliance-driven but has real economic implications if exercised at scale.
Ratify the audit committee’s appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2026.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | NEXPOINT ASSET MANAGEMENT, L.P. | 30.72% | 5,789,877 | $78M |
| 2 | NEXPOINT ASSET MANAGEMENT, L.P. | 19.36% | 3,649,758 | $49M |
| 3 | BlackRock, Inc. | 2.06% | 388,949 | $5M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 1.64% | 309,476 | $4M |
| 5 | INDEPENDENT FINANCIAL GROUP, LLC | 1.47% | 276,601 | $4M |
| 6 | RAYMOND JAMES FINANCIAL INC | 1.34% | 253,196 | $3M |
| 7 | STATE STREET CORP | 0.93% | 175,562 | $2M |
| 8 | MORGAN STANLEY | 0.87% | 164,101 | $2M |
| 9 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 0.83% | 155,715 | $2M |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 0.82% | 154,396 | $2M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.